Nifty
Sensex
:
:
25145.50
82029.98
-81.85 (-0.32%)
-297.07 (-0.36%)

Pharmaceuticals & Drugs

Rating :
46/99

BSE: 532878 | NSE: ALPA

88.49
14-Oct-2025
  • Open
  • High
  • Low
  • Previous Close
  •  90.31
  •  90.31
  •  88.2
  •  89.04
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  7806
  •  693740.81
  •  137.3
  •  87.44

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 186.10
  • 7.09
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 183.92
  • N/A
  • 1.02

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 57.29%
  • 0.68%
  • 37.15%
  • FII
  • DII
  • Others
  • 0.35%
  • 0.00%
  • 4.53%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.69
  • 2.88
  • 6.55

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -2.72
  • -9.19
  • -10.08

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.03
  • 21.88
  • 15.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 14.57
  • 11.77
  • 11.71

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.94
  • 1.17
  • 1.26

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 7.19
  • 8.36
  • 8.69

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 25
Jun 24
Var%
Mar 25
Mar 24
Var%
Dec 24
Dec 23
Var%
Sep 24
Sep 23
Var%
Net Sales
19.11
21.44
-10.87%
39.92
23.61
69.08%
26.15
27.31
-4.25%
24.94
32.39
-23.00%
Expenses
18.69
20.91
-10.62%
39.72
20.10
97.61%
25.41
24.88
2.13%
21.62
29.04
-25.55%
EBITDA
0.43
0.53
-18.87%
0.19
3.51
-94.59%
0.74
2.43
-69.55%
3.32
3.35
-0.90%
EBIDTM
2.22%
2.48%
0.49%
14.86%
2.84%
8.91%
13.31%
10.35%
Other Income
11.95
5.16
131.59%
2.48
3.96
-37.37%
8.80
3.53
149.29%
6.91
2.95
134.24%
Interest
0.05
0.05
0.00%
0.02
0.29
-93.10%
0.09
0.02
350.00%
0.05
0.02
150.00%
Depreciation
0.55
0.54
1.85%
0.58
0.53
9.43%
0.55
0.66
-16.67%
0.53
0.49
8.16%
PBT
11.77
5.10
130.78%
2.08
6.67
-68.82%
8.90
5.30
67.92%
9.65
5.79
66.67%
Tax
0.00
0.00
0
4.20
3.12
34.62%
0.00
0.79
-100.00%
1.96
0.00
0
PAT
11.77
5.10
130.78%
-2.13
3.55
-
8.90
4.51
97.34%
7.69
5.79
32.82%
PATM
61.58%
23.77%
-5.32%
15.05%
34.05%
16.52%
30.82%
17.87%
EPS
5.59
2.42
130.99%
-1.01
1.69
-
4.23
2.14
97.66%
3.65
2.75
32.73%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Net Sales
110.12
112.45
108.74
92.96
112.27
97.55
85.97
77.99
62.85
63.45
53.59
Net Sales Growth
5.13%
3.41%
16.98%
-17.20%
15.09%
13.47%
10.23%
24.09%
-0.95%
18.40%
 
Cost Of Goods Sold
67.45
70.20
68.04
54.94
69.77
59.47
51.00
48.83
36.24
36.32
27.88
Gross Profit
42.67
42.25
40.70
38.01
42.49
38.09
34.97
29.16
26.61
27.13
25.71
GP Margin
38.75%
37.57%
37.43%
40.89%
37.85%
39.05%
40.68%
37.39%
42.34%
42.76%
47.98%
Total Expenditure
105.44
107.70
100.63
84.88
101.61
89.86
82.61
76.84
58.92
56.34
47.33
Power & Fuel Cost
-
2.84
3.02
3.04
2.64
2.43
2.21
2.01
1.76
1.58
1.49
% Of Sales
-
2.53%
2.78%
3.27%
2.35%
2.49%
2.57%
2.58%
2.80%
2.49%
2.78%
Employee Cost
-
14.39
13.29
12.17
11.93
11.75
11.82
12.04
10.26
8.67
7.20
% Of Sales
-
12.80%
12.22%
13.09%
10.63%
12.05%
13.75%
15.44%
16.32%
13.66%
13.44%
Manufacturing Exp.
-
3.01
3.55
3.52
3.67
2.86
2.07
2.24
1.81
1.72
1.35
% Of Sales
-
2.68%
3.26%
3.79%
3.27%
2.93%
2.41%
2.87%
2.88%
2.71%
2.52%
General & Admin Exp.
-
3.04
2.77
2.07
3.45
3.05
3.45
3.20
2.20
3.02
3.84
% Of Sales
-
2.70%
2.55%
2.23%
3.07%
3.13%
4.01%
4.10%
3.50%
4.76%
7.17%
Selling & Distn. Exp.
-
8.28
5.95
5.16
5.79
4.49
5.34
5.00
4.12
3.04
2.73
% Of Sales
-
7.36%
5.47%
5.55%
5.16%
4.60%
6.21%
6.41%
6.56%
4.79%
5.09%
Miscellaneous Exp.
-
5.94
4.02
3.97
4.35
5.82
6.73
3.51
2.53
1.99
2.73
% Of Sales
-
5.28%
3.70%
4.27%
3.87%
5.97%
7.83%
4.50%
4.03%
3.14%
5.30%
EBITDA
4.68
4.75
8.11
8.08
10.66
7.69
3.36
1.15
3.93
7.11
6.26
EBITDA Margin
4.25%
4.22%
7.46%
8.69%
9.49%
7.88%
3.91%
1.47%
6.25%
11.21%
11.68%
Other Income
30.14
23.35
14.89
9.37
10.78
4.40
2.91
5.30
4.86
5.14
5.75
Interest
0.21
0.23
0.36
0.22
0.22
0.08
0.20
0.57
1.07
1.71
1.45
Depreciation
2.21
2.20
1.95
1.33
1.66
1.23
3.16
3.12
3.07
2.78
0.83
PBT
32.40
25.67
20.68
15.89
19.56
10.79
2.91
2.76
4.64
7.75
9.74
Tax
6.16
6.16
3.91
3.31
5.47
3.54
1.05
1.74
1.83
3.12
2.89
Tax Rate
19.01%
24.00%
18.91%
20.83%
27.97%
32.81%
36.08%
63.04%
39.44%
55.42%
29.67%
PAT
26.23
19.50
16.78
12.58
14.09
7.25
1.85
1.01
2.81
2.52
6.85
PAT before Minority Interest
26.23
19.50
16.78
12.58
14.09
7.25
1.85
1.01
2.81
2.52
6.85
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
23.82%
17.34%
15.43%
13.53%
12.55%
7.43%
2.15%
1.30%
4.47%
3.97%
12.78%
PAT Growth
38.42%
16.21%
33.39%
-10.72%
94.34%
291.89%
83.17%
-64.06%
11.51%
-63.21%
 
EPS
12.49
9.29
7.99
5.99
6.71
3.45
0.88
0.48
1.34
1.20
3.26

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Shareholder's Funds
171.43
151.91
134.58
121.73
107.64
100.37
98.49
97.55
94.73
93.41
Share Capital
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
21.04
Total Reserves
150.39
130.87
113.54
100.69
86.60
79.33
77.45
76.51
73.69
72.36
Non-Current Liabilities
4.49
2.40
3.06
4.70
0.23
-0.73
0.24
-0.15
0.44
0.55
Secured Loans
0.00
0.00
0.78
2.12
0.01
0.19
0.41
0.61
0.47
0.00
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Current Liabilities
46.70
28.07
29.63
28.81
32.50
20.79
22.31
23.36
29.71
52.40
Trade Payables
18.69
11.78
15.06
14.92
24.73
13.70
13.19
13.27
13.94
18.62
Other Current Liabilities
22.42
9.73
10.89
8.90
5.80
4.11
5.83
3.84
4.08
4.91
Short Term Borrowings
0.03
4.46
0.00
2.34
0.00
0.00
1.05
5.18
10.16
24.23
Short Term Provisions
5.56
2.11
3.68
2.65
1.97
2.97
2.24
1.07
1.53
4.64
Total Liabilities
222.62
182.38
167.27
155.24
140.37
120.43
121.04
120.76
124.88
146.36
Net Block
20.65
11.47
7.04
9.32
7.21
6.42
7.78
10.17
11.25
14.64
Gross Block
51.22
39.84
33.46
34.41
30.64
40.12
38.85
38.12
36.15
34.74
Accumulated Depreciation
30.57
28.37
26.42
25.09
23.43
33.71
31.07
27.96
24.90
20.10
Non Current Assets
30.14
21.39
18.14
17.23
19.28
24.96
26.96
23.04
20.23
27.49
Capital Work in Progress
0.00
0.00
0.00
0.00
1.57
0.81
0.12
0.00
0.00
0.00
Non Current Investment
7.37
6.87
6.43
5.93
10.15
17.29
18.63
12.88
8.98
12.16
Long Term Loans & Adv.
0.72
0.52
1.45
0.22
0.23
0.24
0.13
0.00
0.00
0.69
Other Non Current Assets
1.40
2.52
3.23
1.76
0.11
0.20
0.30
0.00
0.00
0.00
Current Assets
192.49
160.98
149.13
138.01
121.09
95.46
94.09
97.72
104.65
118.87
Current Investments
110.50
91.14
72.03
68.70
40.69
39.30
29.96
17.68
7.93
0.00
Inventories
17.64
13.67
12.64
15.46
16.56
12.55
14.04
13.72
13.04
15.00
Sundry Debtors
46.83
41.15
46.73
38.04
35.43
24.59
30.00
26.02
29.16
34.34
Cash & Bank
2.22
1.71
8.81
1.58
10.51
6.17
0.90
21.34
36.68
36.64
Other Current Assets
15.30
0.63
3.10
4.74
17.90
12.86
19.19
18.95
17.84
32.88
Short Term Loans & Adv.
13.41
12.69
5.82
9.50
15.50
11.58
17.55
17.52
16.29
22.15
Net Current Assets
145.79
132.92
119.50
109.20
88.59
74.68
71.77
74.36
74.94
66.47
Total Assets
222.63
182.37
167.27
155.24
140.37
120.42
121.05
120.76
124.88
146.36

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Cash From Operating Activity
18.32
3.65
8.90
9.94
-1.70
17.78
-1.00
-12.70
16.99
-21.85
PBT
25.82
20.76
15.68
19.56
10.78
2.91
2.76
4.64
5.63
9.74
Adjustment
-15.71
-9.42
-2.38
-7.96
0.73
5.88
0.79
0.82
0.61
-0.21
Changes in Working Capital
12.28
-4.06
-0.80
1.45
-10.35
10.15
-2.39
-16.33
13.85
-28.49
Cash after chg. in Working capital
22.39
7.29
12.50
13.06
1.16
18.94
1.16
-10.87
20.09
-18.96
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-4.07
-3.64
-3.60
-3.12
-2.86
-1.16
-2.17
-1.83
-3.10
-2.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-12.36
-13.34
2.13
-15.61
5.86
-11.16
-14.66
-11.46
-1.71
-8.03
Net Fixed Assets
-11.38
-6.38
0.95
-2.20
-1.39
-1.95
-0.86
-1.97
-1.42
-0.49
Net Investments
-19.99
-20.42
-3.12
-23.80
5.68
-8.18
-18.09
-17.85
-1.36
-12.02
Others
19.01
13.46
4.30
10.39
1.57
-1.03
4.29
8.36
1.07
4.48
Cash from Financing Activity
-5.44
2.58
-3.79
5.44
0.18
-1.35
-4.78
8.83
-15.23
-5.62
Net Cash Inflow / Outflow
0.51
-7.10
7.24
-0.23
4.34
5.27
-20.44
-15.33
0.05
-35.50
Opening Cash & Equivalents
3.11
10.21
1.58
1.80
6.17
0.90
21.34
36.68
36.63
52.74
Closing Cash & Equivalent
3.62
3.11
8.81
1.58
10.51
6.17
0.90
21.35
36.68
17.24

Financial Ratios

Consolidated /

Standalone
Description
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Book Value (Rs.)
81.48
72.20
63.96
57.86
51.16
47.70
46.81
46.36
45.02
44.39
ROA
9.63%
9.60%
7.80%
9.53%
5.56%
1.54%
0.84%
2.29%
1.86%
4.99%
ROE
12.06%
11.71%
9.82%
12.29%
6.97%
1.86%
1.03%
2.92%
2.68%
7.61%
ROCE
15.76%
14.31%
12.19%
16.81%
10.42%
3.09%
3.26%
5.47%
6.59%
9.61%
Fixed Asset Turnover
2.47
2.97
2.74
3.45
2.76
2.18
2.03
1.69
1.79
1.96
Receivable days
142.78
147.50
166.43
119.43
112.28
115.88
131.09
160.24
182.65
186.53
Inventory Days
50.81
44.15
55.18
52.06
54.46
56.45
64.97
77.71
80.64
71.40
Payable days
79.22
71.98
99.58
103.71
117.94
64.11
67.42
88.04
111.78
111.89
Cash Conversion Cycle
114.37
119.67
122.02
67.77
48.80
108.22
128.63
149.91
151.51
146.05
Total Debt/Equity
0.00
0.03
0.02
0.05
0.00
0.00
0.02
0.06
0.11
0.26
Interest Cover
111.73
58.58
72.07
90.32
139.47
15.82
5.85
5.33
4.30
7.73

News Update:


  • Alpa Lab - Quarterly Results
    13th Aug 2025, 19:26 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.